학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 32건 | 목록 1~10
Academic Journal
Pieren M; BioVersys AG, Basel, Switzerland.; Abáigar Gutiérrez-Solana A; CTI Laboratory Services S.L., Ibaizabal bidea, 702, 48160 Derio, Biscay, Spain.; Antonijoan Arbós RM; Institut de Recerca de l'HSCSP, IIB Sant Pau, Centre d'Investigació de Medicaments (CIM), Barcelona, Spain.; Boyle GW; GSK, Stevenage, UK.; Davila M; BioVersys AG, Basel, Switzerland.; Davy M; GSK, Stevenage, UK.; Gitzinger M; BioVersys AG, Basel, Switzerland.; BioVersys SAS, Lille, France.; Husband L; BioVersys SAS, Lille, France.; Martínez-Martínez MS; GSK, Tres Cantos, Spain.; Mazarro DO; Clinical Trials Unit, Clinical Pharmacology Department, Facultad de Medicina, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.; Pefani E; GSK, Stevenage, UK.; Penman SL; GSK, London, UK.; Remuiñán MJ; GSK, Tres Cantos, Spain.; Vlasakakis G; GSK, Philadelphia, PA, USA.; Zeitlinger M; Department of Clinical Pharmacology, Vienna University Hospital, Medical University of Vienna, Vienna, Austria.; Dale GE; BioVersys AG, Basel, Switzerland.; BioVersys SAS, Lille, France.
Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Academic Journal
Guerrero C; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) number CB16/12/00369, Pamplona, Spain.; Puig N; Department of Hematology, Hospital Universitario de Salamanca Hematología, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain.; Cedena MT; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Calasanz MJ; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) number CB16/12/00369, Pamplona, Spain.; Gutierrez NC; Department of Hematology, Hospital Universitario de Salamanca Hematología, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain.; Fernandez M; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Oriol A; Department of Hematology, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain.; Ríos-Tamayo R; Department of Hematology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.; Hernandez MT; Department of Hematology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.; Martínez-Martínez R; Department of Hematology, Hospital Universitario San Carlos, Madrid, Spain.; Bargay J; Department of Hematology, Hospital Universitario Son Llatzer, Institut d'Investigacio Illes Balears, Palma de Mallorca, Spain.; de Arriba F; Department of Hematology, Hospital Morales Meseguer, Instituto Murciano de Investigación Biosanitaria-Pascual Parrilla, Universidad de Murcia, Murcia, Spain.; Palomera L; Department of Hematology, Hospital Clínico Lozano Blesa, Zaragoza, Spain.; Gonzalez-Rodriguez AP; Department of Hematology, Hospital Central de Asturias, Oviedo, Spain.; Gonzalez Perez MS; Department of Hematology, Complejo Hospitalario Universitario de Santiago de Compostela, Servizio Galego de Saúde, Compostela, Spain.; Orfao A; Department of Hematology, Hospital Universitario de Salamanca Hematología, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain.; Mateos MV; Department of Hematology, Hospital Universitario de Salamanca Hematología, Instituto de investigación Biomédica de Salamanca, Salamanca, Spain.; Martinez-Lopez J; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Rosiñol L; Department of Hematology, Hospital Clínic, Institut de Recerca Biomedica August Pi i Suñer, Barcelona, Spain.; Bladé J; Department of Hematology, Hospital Clínic, Institut de Recerca Biomedica August Pi i Suñer, Barcelona, Spain.; Lahuerta JJ; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.; San-Miguel JF; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) number CB16/12/00369, Pamplona, Spain.; Paiva B; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) number CB16/12/00369, Pamplona, Spain.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Sánchez-Sánchez JL; MOVE-IT Research Group, Department of Physical Education, Faculty of Education Sciences, University of Cadiz, Cadiz, Spain.; Health Sciences Department, Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Insitut de Viellissement, CHU Toulouse, Gerontopole de Toulouse, Toulouse, France.; Udina C; Parc Sanitari Pere Virgili, Barcelona, Spain.; RE-FiT Bcn Research Group, Vall Hebron Research Institute, Barcelona, Spain.; Medina-Rincón A; Parc Sanitari Pere Virgili, Barcelona, Spain.; RE-FiT Bcn Research Group, Vall Hebron Research Institute, Barcelona, Spain.; Esbrí-Victor M; Geriatrics Department, Complejo Hospitalario Universitario de Albacete (CHUA), Albacete, Spain.; Bartolomé-Martín I; Geriatrics Department, Hospital Universitario de Guadalajara (HUG), Guadalajara, Spain.; Moral-Cuesta D; Geriatrics Department, Hospital Universitario de Navarra (HUN), C/Irunlarrea s/n 31008, Pamplona, Spain.; Marín-Epelde I; Geriatrics Department, Hospital Universitario de Navarra (HUN), C/Irunlarrea s/n 31008, Pamplona, Spain.; Ramon-Espinoza F; Functional Recovery Unit, Hospital San Juan de Dios (HSJD), Pamplona, Spain.; Latorre MS; Geriatrics Department, Hospital Universitario de Navarra (HUN), C/Irunlarrea s/n 31008, Pamplona, Spain.; Idoate F; Radiology Department, Mutua Navarra, Pamplona, Spain.; Goñi-Sarriés A; Mental Health Network, Navarra Healthcare System, Pamplona, Spain.; Martínez-Martínez B; Mental Health Network, Navarra Healthcare System, Pamplona, Spain.; Bonet RE; Mental Health Network, Navarra Healthcare System, Pamplona, Spain.; Librero J; Health Sciences Department, Universidad Pública de Navarra (UPNA), Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Casas-Herrero Á; Health Sciences Department, Universidad Pública de Navarra (UPNA), Pamplona, Spain. alvaro.casas.herrero@navarra.es.; Geriatrics Department, Hospital Universitario de Navarra (HUN), C/Irunlarrea s/n 31008, Pamplona, Spain. alvaro.casas.herrero@navarra.es.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain. alvaro.casas.herrero@navarra.es.; CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain. alvaro.casas.herrero@navarra.es.
Publisher: BioMed Central Country of Publication: England NLM ID: 100968548 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2318 (Electronic) Linking ISSN: 14712318 NLM ISO Abbreviation: BMC Geriatr Subsets: MEDLINE
Academic Journal
Valvecchia G; From the Centro de Ojos Quilmes, Quilmes, Buenos Aires, Argentina (Valvecchia, Masseroni); the Centro de Ojos Martínez, Martínez, Buenos Aires, Argentina (Kaufer, Idiart); the Clínica de ojos y cirugía refractiva Dr. Carlos Ferroni, Rosario, Santa Fe, Argentina (C. Ferroni, V. Ferroni); the Instituto Zaldívar, Mendoza, Argentina (Zaldívar, Marino); Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Matemática, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina (Nuñez); Laboratorios POEN S.A.U., Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina (del Papa, Passerini).; Kaufer RFerroni CZaldívar RMasseroni MIdiart CFerroni VMarino FNuñez MDel Papa MPasserini MS
Publisher: Wolters Kluwer on behalf of ASCRS and ESCRS Country of Publication: United States NLM ID: 8604171 Publication Model: Print Cited Medium: Internet ISSN: 1873-4502 (Electronic) Linking ISSN: 08863350 NLM ISO Abbreviation: J Cataract Refract Surg Subsets: MEDLINE
Academic Journal
Nuermberger EL; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.; Martínez-Martínez MS; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Sanz O; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Urones B; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Esquivias J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Soni H; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.; Tasneen R; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.; Tyagi S; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.; Li SY; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.; Converse PJ; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA.; Boshoff HI; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Robertson GT; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.; Besra GS; Institute of Microbiology and Infection, School of Biosciences, University of Birminghamgrid.6572.6, Birmingham, United Kingdom.; Abrahams KA; Institute of Microbiology and Infection, School of Biosciences, University of Birminghamgrid.6572.6, Birmingham, United Kingdom.; Upton AM; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA.; Mdluli K; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA.; Boyle GW; GSK: Research, GlaxoSmithKline R&D, Ware, United Kingdom.; Turner S; GSK: Research, GlaxoSmithKline R&D, Ware, United Kingdom.; Fotouhi N; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA.; Cammack NC; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Siles JM; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Alonso M; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Escribano J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Lelievre J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Rullas-Trincado J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Pérez-Herrán E; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Bates RH; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Maher-Edwards G; GSK, Brentford, Middlesex, United Kingdom.; Barros D; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Ballell L; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.; Jiménez E; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.
Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Academic Journal
Flipo M; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; Frita R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Bourotte M; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; BioVersys SAS, Lille, France.; Martínez-Martínez MS; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Boesche M; Cellzome GmbH . A GSK Company, 69117 Heidelberg, Germany.; Boyle GW; GSK, David Jack Centre for R&D, Park Road, Ware, Hertfordshire SG12 ODP, UK.; Derimanov G; GSK, Clinical Pharmacology and Experimental Medicine, 1250 South Collegeville Road, Collegeville, PA 19426, USA.; Drewes G; Cellzome GmbH . A GSK Company, 69117 Heidelberg, Germany.; Gamallo P; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Ghidelli-Disse S; Cellzome GmbH . A GSK Company, 69117 Heidelberg, Germany.; Gresham S; GSK, David Jack Centre for R&D, Park Road, Ware, Hertfordshire SG12 ODP, UK.; Jiménez E; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; de Mercado J; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Pérez-Herrán E; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Porras-De Francisco E; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Rullas J; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Casado P; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Leroux F; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France.; Piveteau C; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; Kiass M; National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium.; Mathys V; National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium.; Soetaert K; National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium.; Megalizzi V; Microbiology, Bioorganic and Macromolecular Chemistry, Facult. de Pharmacie, Universit. Libre de Bruxelles, Brussels, Belgium.; Tanina A; Microbiology, Bioorganic and Macromolecular Chemistry, Facult. de Pharmacie, Universit. Libre de Bruxelles, Brussels, Belgium.; Wintjens R; Microbiology, Bioorganic and Macromolecular Chemistry, Facult. de Pharmacie, Universit. Libre de Bruxelles, Brussels, Belgium.; Antoine R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Brodin P; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France.; Delorme V; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Moune M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Djaout K; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Slupek S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Kemmer C; BioVersys AG, Basel, Switzerland.; Gitzinger M; BioVersys AG, Basel, Switzerland.; Ballell L; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Mendoza-Losana A; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Lociuro S; BioVersys AG, Basel, Switzerland.; Deprez B; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France.; Barros-Aguirre D; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Remuiñán MJ; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Willand N; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; Baulard AR; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Fernández Álvaro E; GSK Global Health, Tres Cantos, Madrid, Spain.; Voong Vinh P; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.; de Cozar C; GSK Global Health, Tres Cantos, Madrid, Spain.; Willé DR; GSK R&D, Stevenage, United Kingdom.; Urones B; GSK Global Health, Tres Cantos, Madrid, Spain.; Cortés A; GSK Global Health, Tres Cantos, Madrid, Spain.; Price A; GSK Global Health, Tres Cantos, Madrid, Spain.; Tran Do Hoang N; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.; Ha Thanh T; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.; McCloskey M; Division of Allergy and Infectious Disease, Center for Emerging and Re-emerging Infectious Diseases University of Washington School of Medicine, Seattle, United States.; Shaheen S; Division of Allergy and Infectious Disease, Center for Emerging and Re-emerging Infectious Diseases University of Washington School of Medicine, Seattle, United States.; Dayao D; Department of Infectious Disease and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, United States.; Martinot A; Department of Infectious Disease and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, United States.; de Mercado J; GSK Global Health, Tres Cantos, Madrid, Spain.; Castañeda P; GSK Global Health, Tres Cantos, Madrid, Spain.; García-Perez A; GSK Global Health, Tres Cantos, Madrid, Spain.; Singa B; Kenya Medical Research Institute, Nairobi, Kenya.; Pavlinac P; Department of Global Health, University of Washington, Seattle, United States.; Walson J; Division of Allergy and Infectious Disease, Center for Emerging and Re-emerging Infectious Diseases University of Washington School of Medicine, Seattle, United States.; Martínez-Martínez MS; GSK Global Health, Tres Cantos, Madrid, Spain.; Arnold SLM; Division of Allergy and Infectious Disease, Center for Emerging and Re-emerging Infectious Diseases University of Washington School of Medicine, Seattle, United States.; Tzipori S; Department of Infectious Disease and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, United States.; Ballell Pages L; GSK Global Health, Tres Cantos, Madrid, Spain.; Baker S; University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Academic Journal
Gold B; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.; Zhang J; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.; Quezada LL; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.; Roberts J; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.; Ling Y; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.; Wood M; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.; Shinwari W; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.; Goullieux L; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.; Evotec (Lyon) SAS, 69007 Lyon, France.; Roubert C; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.; Evotec (Lyon) SAS, 69007 Lyon, France.; Fraisse L; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.; Bacqué E; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.; Evotec (Lyon) SAS, 69007 Lyon, France.; Lagrange S; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.; Evotec (Lyon) SAS, 69007 Lyon, France.; Filoche-Rommé B; Sanofi, Integrated Drug Discovery, 94400 Vitry sur Seine, France.; Vieth M; Lilly Biotechnology Center, Eli Lilly and Company, 10290 Campus Point Dr, San Diego, California 92121, United States.; Hipskind PA; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.; Jungheim LN; YourEncore, 20 North Meridian Street, Indianapolis, Indiana 46204, United States.; Aubé J; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.; Scarry SM; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.; McDonald SL; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.; Li K; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.; Perkowski A; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.; Nguyen Q; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.; Dartois V; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey 07103, United States.; Zimmerman M; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey 07103, United States.; Olsen DB; Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States.; Young K; Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States.; Bonnett S; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States.; Joerss D; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States.; Parish T; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States.; Boshoff HI; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Bethesda, Maryland 20892, United States.; Arora K; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Bethesda, Maryland 20892, United States.; Barry CE 3rd; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Bethesda, Maryland 20892, United States.; Guijarro L; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.; Anca S; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.; Rullas J; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.; Rodríguez-Salguero B; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.; Martínez-Martínez MS; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.; Porras-De Francisco E; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.; Cacho M; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.; Barros-Aguirre D; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.; Smith P; Independent Consultant, Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.; Berthel SJ; Panorama Global, 2101 4th Avenue, Suite 2100, Seattle, Washington 98121, United States.; Nathan C; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.; Bates RH; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Martínez-Martínez MS
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어